These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29113172)

  • 21. Breast Cancer Subtype as a Predictor of Lymph Node Metastasis according to the SEER Registry.
    Mattes MD; Bhatia JK; Metzger D; Ashamalla H; Katsoulakis E
    J Breast Cancer; 2015 Jun; 18(2):143-8. PubMed ID: 26155290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer.
    Fu DY; Tan HS; Wei JL; Zhu CR; Jiang JX; Zhu YX; Cai FL; Chong MH; Ren CL
    Tumour Biol; 2015 Sep; 36(10):8025-34. PubMed ID: 25971583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer.
    Urban P; Vuaroqueaux V; Labuhn M; Delorenzi M; Wirapati P; Wight E; Senn HJ; Benz C; Eppenberger U; Eppenberger-Castori S
    J Clin Oncol; 2006 Sep; 24(26):4245-53. PubMed ID: 16963728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction between body mass index and hormone-receptor status as a prognostic factor in lymph-node-positive breast cancer.
    Chung IY; Lee JW; Lee JS; Park YR; Min YH; Lee Y; Yoon TI; Sohn G; Lee SB; Kim J; Kim HJ; Ko BS; Son BH; Ahn SH
    PLoS One; 2017; 12(3):e0170311. PubMed ID: 28248981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of tumor subtypes in male breast cancer: a population-based study.
    Leone JP; Leone J; Zwenger AO; Iturbe J; Vallejo CT; Leone BA
    Breast Cancer Res Treat; 2015 Aug; 152(3):601-9. PubMed ID: 26126972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis.
    Qiao W; Jia Z; Liu H; Liu Q; Zhang T; Guo W; Li P; Deng M; Li S
    PLoS One; 2017; 12(10):e0186191. PubMed ID: 29016671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vav3 oncogene is upregulated and a poor prognostic factor in breast cancer patients.
    Chen X; Chen SI; Liu XA; Zhou WB; Ma RR; Chen L
    Oncol Lett; 2015 May; 9(5):2143-2148. PubMed ID: 26137028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LAMP1 expression is associated with poor prognosis in breast cancer.
    Wang Q; Yao J; Jin Q; Wang X; Zhu H; Huang F; Wang W; Qiang J; Ni Q
    Oncol Lett; 2017 Oct; 14(4):4729-4735. PubMed ID: 29085473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estradiol-regulated expression of the immunophilins cyclophilin 40 and FKBP52 in MCF-7 breast cancer cells.
    Kumar P; Mark PJ; Ward BK; Minchin RF; Ratajczak T
    Biochem Biophys Res Commun; 2001 Jun; 284(1):219-25. PubMed ID: 11374893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognostic value and initial exploratory research on TNM staging method of tumor deposits in stage III colon cancer].
    Qin Q; Yang L; Zhou AP; Wang JW; Zhong DS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1152-1158. PubMed ID: 31874531
    [No Abstract]   [Full Text] [Related]  

  • 32. MDM2 amplification is an independent prognostic feature of node-negative, estrogen receptor-positive early-stage breast cancer.
    Choschzick M; Heilenkötter U; Lebeau A; Jaenicke F; Terracciano L; Bokemeyer C; Sauter G; Simon R
    Cancer Biomark; 2010-2011; 8(2):53-60. PubMed ID: 21896991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lack of progesterone receptor expression predicts poor prognosis in patients with operable ER-positive invasive breast cancer].
    Ma RM; Chen CZ; Lin CQ; Zhang W; Guo GL
    Zhonghua Zhong Liu Za Zhi; 2016 Sep; 38(9):687-92. PubMed ID: 27647402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High scavenger receptor class B type I expression is related to tumor aggressiveness and poor prognosis in breast cancer.
    Yuan B; Wu C; Wang X; Wang D; Liu H; Guo L; Li XA; Han J; Feng H
    Tumour Biol; 2016 Mar; 37(3):3581-8. PubMed ID: 26456958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Correlation of miR-195 with invasiveness and prognosis of breast cancer].
    Song CG; Wu XY; Wang C; Fu FM; Shao ZM
    Zhonghua Wai Ke Za Zhi; 2012 Apr; 50(4):353-6. PubMed ID: 22800791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer.
    Cao YW; Li WQ; Wan GX; Li YX; Du XM; Li YC; Li F
    J Exp Clin Cancer Res; 2014 Nov; 33(1):97. PubMed ID: 25420528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is the TNM staging system for breast cancer still relevant in the era of biomarkers and emerging personalized medicine for breast cancer - an institution's 10-year experience.
    Orucevic A; Chen J; McLoughlin JM; Heidel RE; Panella T; Bell J
    Breast J; 2015; 21(2):147-54. PubMed ID: 25600504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expressions of NEDD9 and E-cadherin correlate with metastasis and poor prognosis in triple-negative breast cancer patients.
    Li P; Sun T; Yuan Q; Pan G; Zhang J; Sun D
    Onco Targets Ther; 2016; 9():5751-5759. PubMed ID: 27703373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small breast epithelial mucin as a useful prognostic marker for breast cancer patients.
    Hao H; Yang L; Wang B; Sang Y; Liu X
    Open Life Sci; 2023; 18(1):20220784. PubMed ID: 38027223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival.
    Sfiligoi C; de Luca A; Cascone I; Sorbello V; Fuso L; Ponzone R; Biglia N; Audero E; Arisio R; Bussolino F; Sismondi P; De Bortoli M
    Int J Cancer; 2003 Feb; 103(4):466-74. PubMed ID: 12478661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.